Skip Navigation



Annals of Oncology Advance Access published online on March 23, 2005
Annals of Oncology, doi:10.1093/annonc/mdi144
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
16/5/835    most recent
mdi144v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Coward, J.
Right arrow Articles by Cunningham, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coward, J.
Right arrow Articles by Cunningham, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society for Medical Oncology

Letter

The effects of capecitabine in Raynaud's disease: a case report

J. Coward 1, N. Maisey 1, and D. Cunningham 1*

1 Royal Marsden Hospital, Sutton, UK

* To whom correspondence should be addressed.
D. Cunningham, E-mail: david.cunningham{at}icr.ac.uk



This article has no Abstract.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.